Views Reference
Display a feed or a list of contents from your site.
Example of the Articles View
Example of the Events View
Example of the Faculty Directory View
Faculty Directory
Aisha Dickerson, PhD, MSPH, studies environmental exposures and their disproportionate impact on autism and dementia risks in underserved communities across the lifespan.
Conan Dickson, PhD ’04, MPH, leverages his experience in health system management to enhance education in health care strategy, finance, and quantitative tools.
Marie Diener-West, PhD ’84, Chair of MPH Program and Professor of Biostatistics, teaches and collaborates in the design, conduct, and analysis of multicenter clinical trials.
George Dimopoulos, PhD, MBA, studies vector-borne diseases and how mosquitoes can be rendered incapable of transmitting human pathogens.
Janet DiPietro, PhD, studies the interface between individual differences in development and physiology, and the implications of the prenatal period for postnatal life.
Shannon Doocy, PhD ’04, studies the health impact of natural disasters and conflict, including refugees and displaced populations, and how to improve humanitarian responses.
David Dowdy, MD, PhD ’08, ScM ’02, studies the implementation of interventions to fight tuberculosis, the world's most deadly infectious disease.
Emmanuel Fulgence Drabo, PhD, MPhil, applies economic epidemiology, health services research, and systems science methods to assess the value of public health interventions.
Matthew Z. Dudley, PhD ’18, MSPH ’14, uses research to improve public health communication and positively impact health behavior, particularly with regard to vaccination.
Anne Duggan, ScD ’85, seeks to strengthen home visiting services for young families to achieve health equity of children and parents, partnering with public and private agencies.
Vadim Dukhanin, MD, MHS’ 15, studies and advocates for patient, caregiver, and public engagement in healthcare delivery, priority setting, and performance management.
Anna Durbin, MD, studies experimental vaccines for SARS-CoV-2, dengue, West Nile, Zika, malaria, and more in human clinical trials and in controlled human infection studies.
Michelle Duren, PhD, MIPA, uses quantitative approaches to advance the state of knowledge on how to promote safe and sustainable transportation systems.